PMGC signs term sheet with Orbit2Orbit for NorthStrive microgravity muscle-loss study

PUBT · 2d ago
PMGC signs term sheet with Orbit2Orbit for NorthStrive microgravity muscle-loss study
  • PMGC signed a non-binding term sheet with Orbit2Orbit for a multi-part partnership spanning space bioscience research, aerospace manufacturing, investment.
  • NorthStrive Biosciences plans a spaceflight mouse study of EL-22, EL-32 to assess muscle retention in microgravity versus Earth controls.
  • A&B Aerospace is set to become Orbit2Orbit’s preferred US manufacturer, including final Mice2Space flight hardware.
  • PMGC plans to invest CAD 200,000 in Orbit2Orbit at CAD 0.8 per share via a private placement tied to a CSE listing plan.
  • Transactions remain subject to due diligence, definitive agreements, corporate approvals, customary closing conditions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PMGC Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608250730PRIMZONEFULLFEED9815469) on August 25, 2026, and is solely responsible for the information contained therein.